504
Views
4
CrossRef citations to date
0
Altmetric
Transfusion

Cytokines in Platelet Concentrates

Pages 473-484 | Received 11 Nov 1997, Published online: 13 Jul 2016

References

  • Vengelen-Tyler, V. (1996). Technical manual, 12th Edn. p.548. Bethesda, MD. American Association of Blood Banks.
  • Heddle, N. M., Klama, L. N., Griffith, L., Roberts, R., Shukla, G. and Kelton, J. G. (1993). A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions, Transfusion, 33, 749–797.
  • Vam Vakas, E. C. and Pineda, A. A. (1996). In Transfusion Reactions, Allergic and anaphylactic reactions, edited by M. A. Popovsky, pp. 81–123, Bethesda, MD. AABB Press.
  • Popovsky, M. A. (1996). Transfusion-related acute lung injury (TRALI). In Transfusion Reactions, edited by M. A. Popovsky, pp. 167–183, Bethesda, MD. AABB Press.
  • Borden, C. W. and Hall, W. H. (1951). Fatal transfusion reactions from massive bacterial contamination of blood. N. Eng. J. Med., 245, 760–5.
  • Goldman, M. and Blajchman, M. A. (1996). Bacterial contamination. In Transfusion Reactions, edited by M. A. Popovsky, pp. 125–165, Bethesda, MD. AABB Press.
  • Dzieczkowski, J. S., Barrett, B. B., Nester, D., Campbell, M., Cook, J., Sugrue, M., Andersen, J. W. and Anderson, K. C. (1995). Characterization of reactions after exclusive transfusion of white cell reduced cellular blood products. Transfusion, 35, 20–25.
  • Federowicz, I., Barrett, B. B., Andersen, J. W., Urashima, M., Popovsky, M. A. and Anderson, K. C. (1996). Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage. Transfusion, 36, 21–28.
  • Heaton, W. A. L., Rebulla, P., Pappalettera, M. and Dzik, W. H. (1997). A comparative analysis of different methods for routine blood component preparation. Transfusion Medicine, 11, 116–129.
  • Blajchman, M. A. (1993). Cytokines in transfusion medicine. Transfusion, 33, 1–3.
  • Wadhwa, M., Seghatchian, M. J., Lubenko, A., Contreras, M., Dilger, P., Bird, C. and Thorpe, R. (1995). Cytokine levels in platelet concentrates: quantitation by bioassays and immunoassays. British Journal of Haematology, 93, 225–234.
  • Snyder, E. L. (1995). The role of cytokines and adhesive molecules in febrile non-hemolytic transfusion reactions. Immunological Investigations, 24, 333–339.
  • Foss, H. D., Herbst, H., Hummel, M., Araujo, I., Latza, U., Rancso, C., Dallenbach, F. and Stein, H. (1994). Patterns of cytokine gene expression in infectious mononucleosis. Blood, 83, 707–712.
  • Muylle, L., Joos, M., Wouters, E., De Bock, R. and Peetermans, M. E. (1993). Increased tumor necrosis α (TNF α), interleukin 1, and interleukin 6 (IL-6) levels in plasma of stored platelet concentrates: Relationship between TNF α and IL-6 levels and febrile transfusion reactions. Transfusion, 33, 195–199.
  • Dinarello, C. A. (1991). Interleukin-1 and interleukin-1 antagonism. Blood, 77, 1627–1652.
  • Klüter, H. (1995). Cytokines in platelet concentrates prepared from buffy coats. Vox Sang, 69, 38–43.
  • Muylle, L. and Peetermans, M. E. (1994). Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates Vox Sang, 66, 14–17.
  • Aye, M. T., Giulivi, A. and Hashemi, S. (1995). Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage. Transfusion, 35, 117–124.
  • Kishimoto, T. (1989). The biology of interleukin-6 Blood, 74, 1–10.
  • Lumadue, J. A., Lanzkron, S. M., Kennedy, S. D., Kuhl, D. T. and Kidder, T. S. (1996). Cytokine induction of platelet activation. American Journal of Clinical Pathology, 106, 795–789.
  • Heddle, N. M., Klama, L., Singer, J., Richards, C., Fedak, P., Walker, I. and Kelton, J. G. (1994). The role of the plasma from platelet concentrates in transfusion reactions. New England Journal of Medicine, 331, 625–628.
  • Flegel, W. A., Wiesneth, M., Stampe, D. and Koemer, K. (1995). Low cytokine contamination in buffy coatderived platelet concentrates without filtration. Transfusion, 35, 917–920.
  • Aggarwal, B. B., Eessalu, T. E. and Hass, P. E. (1985). Characterization of receptors for human tumor necrosis factor and their regulation by gamma-interferon. Nature, 318, 665–667.
  • Spriggs, D. R., Sherman, M. L., Frei, E. III and Kufe, D. W. (1987). Clinical studies with tumour necrosis factor. In Tumour necrosis factor and related cytotoxins. 131st Ciba Foundation Symposium. Chichester, pp. 206–227, UK. Wiley.
  • Blick, M. B., Sherwin, S. A., Rosenblum, M. G. and Gutterman, J. U. (1986). A phase I trial of recombinant tumor necrosis factor (rTNF) in cancer patients (abstract). Proceedings of the American Society of Clinical Oncology, 5, 14.
  • Taniguchi, T., Matsui, H., Fujita, T., Takaoka, C., Kashima, N., Yoshimoto, R. and Hamuro, J. (1983). Structure and expression of a doned cDNA for human interleukin-2. Nature, 302, 305–310.
  • Cook, D. N. (1996). The role of MIP-lα in inflammation and Hematopoiesis. Journal of Leukocyte Biology, 59, 61–66.
  • Baggiolini, M. and Dahinden, C. A. (1994) CC chemokines in allergic inflammation. Immunology Today, 15, 127–133.
  • Braun, R. K., Franchini, M., Erard, F., Rihs, S., De Vries, I. J., Blaser, K., Hansel, T. T. and Walker, C. (1993). Human peripheral blood eosinophils produce and release interleukin-8 on stimulation with calcium ionophore. European Journal of Immunology, 23, 956–960.
  • Saito, S., Kasahara, T., Sakakura, S., Enomoto, M., Umekage, H., Harada, N., Mori, T., Nishikawa, K., Narita, N. and Ichijo, M. (1994). Interleukin-8 production by CD16-CD56 bright natural killer cells in the human early pregnancy decidua. Biochemical and Biophysical Research Communication, 200, 378–383.
  • Jeannin, P., Delneste, Y., Gosset, P., Molet, S., Lassalle, P., Hamid, Q., Tsicopoulos, A. and Tonnel, A. B. (1994). Histamine induces interleukin-8 secretion by endothelial cells. Blood, 84, 2229–2233.
  • Baggiolini, M., Walz, A. and Kunkel, S. L. (1989). Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. Journal of Clinical Investigation, 84, 1045–1049.
  • Dahinden, C. A., Kurimoto, Y., De Week, A.L., Lindley, I., Dewald, B. and Baggiolini, M. (1989). The neutrophil-activating peptide NAF/NAP-1 induces histamine and leukotriene release by interleukin 3-primed basophils. Journal of Experimental Medicine, 170, 1787–1792.
  • Rot, A. (1991). Some aspects of NAP-1 pathophysiology: Lung damage caused by a blood-bome cytokine. Advanced Experimental Medical Biology, 305, 127–135.
  • Kunkel, S. L., Standiford, T., Kasahara, K. and Strieter, R. M. (1991). Interleukin-8 (IL-8): the major neutrophil chemotactic factor in the lung. Experimental Lung Research, 17, 17–23.
  • Stack, G. and Snyder, E. L. (1994). Cytokine generation in stored platelet concentrates. Transfusion, 34, 20–25.
  • Bubel, S., Wilhelm, D., Entelmann, M., Kirchner, H. and Kliiter, H. (1996). Chemokines in stored platelet concentrates. Transfusion, 36, 445–449.
  • Muylle, L. (1995). The role of cytokines in blood transfusion reactions. Blood Reviews, 9, 77–83.
  • Klüter, H., Schlenke, P., Müller-Steinhardt, M., Paulsen, M. and Kirchner, H. (1997). Impact of buffy coat storage on the generation of inflammatory cytokines and platelet activation. Transfusion, 37, 362–367.
  • Darbonne, W. C., Rice, G. C., Mohler, M. A., Apple, T., Hebert, C. A., Valente, A. J. and Baker, J. B. (1991). Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. Journal of Clinical Investigation, 88, 1362–1369.
  • Synder, E. L., Mechanic, S., Baril, L. and Davenport, R. (1996). Removal of soluble biologic response modifiers (complement and chemokines) by a bedside white cellreduction filter. Transfusion, 36, 707–713.
  • Zucker, M. B. and Katz, I. R. (1991). Platelet factor 4: Production, structure and physiologic and immunologic action. Proceedings of the Society of Experimental Biological Medicine, 198, 693–702.
  • Klinger, M. H. F., Wilhelm, D., Bubel, S., Sticherling, M., Schröder, J.-M. and Kühnel, W. (1995). Immunocytochemical localization of the chemokines RANTES and MIP-1α within human platelets and their release during storage. International Archives of Allergy and Immunology, 107, 541–546.
  • Chihara, J., Hayashi, N., Kakazu, T., Yamamoto, T., Kurachi, D. and Nakajima, S. (1994). RANTES augments radical oxygen products from eosinophils. International Archives of Allergy and Immunology, 104, 52–53.
  • Baggiolini, M., Dahinden, C. A. (1994). CC chemokines in allergic inflammation. Immunology Today, 15, 127–133.
  • Grabstein, K., Dower, S., Gillis, S., Urdal, D. and Larsen, A. (1986). Expression of interleukin 2, interferon-gamma, and the IL-2 receptor by human periphal blood lymphocytes. Journal of Immunology, 136, 4503–4508.
  • McCartney-Francis, N., Mizel, D., Wong, H., Wahl, L. M. and Wahl, S. M. (1990). TGF-β regulates production of growth factors and TGF-β by human peripheral blood monocytes. Growth Factors, 4, 27–35.
  • Wahl, S. M. (1992). Transforming growth factor beta in inflammation: A cause and a cure. Journal of Clinical Immunology, 12, 61–74.
  • Muylle, L., Wouters, E. and Peetermans, M. E. (1996). Febrile reactions to platelet transfusion; The effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method. Transfusion, 35, 886–890.
  • Heddle, N. M., Klama, L., Meyer, R., Roberts, R., Walker, I., O'Hoski, P., Levine, M., Podlosky, L. and Boshkov, L. (1996). A comparison of two interventions to prevent platelet reactions, Transfusion, 36, 47S.
  • Oksanen, K., Ebeling, F., Kekomäki, R., Elonen, E., Sahlstedt, L., Volin, L. and Myllylä, G. (1994). Adverse reactions to platelet transfusions are reduced by use of platelet concentrates derived from buffy coat. Vox Sang, 67, 356–361.
  • Bishop, D., Tandy, N., Anderson, N., Bessos, H. and Seghatachian, M. J. (1995). A clinical laboratory study of platelet concentrates produced by pooled buffy coat and single donor apheresis technologies. Transfusion Science, 16, 187–188.
  • Chambers, L. A., Kruskall, M. S., Pacini, D. G., Donovan, L. M. (1990). Febrile reactions after platelet transfusion: the effect of single versus multiple donors. Transfusion, 30, 219–221.
  • Mangano, M. M., Chambers, L. A. and Kruskall, M. S. (1991). Limited efficacy of leukopoor platelets for prevention of febrile transfusion reactions. American Journal of Clinical Pathology, 95, 733–738.
  • Muylle, L., Wouters, E., De Bock, R. and Peetermans, M. E. (1992). Transfusion reactions to platelet concentrates: The effect of the storage time of the concentrate. Transfusion Medicine, 2, 289–293.
  • Muir, J. C., Jacobson, S., Herschel, L. and AuBuchon, J. P. (1994). Does pre-storage leukocyte reduction of blood components reduce the risk of febrile reactions in sensitized patients Blood, 84, 464a.
  • Anderson, K. C., Gorgone, B. C., Wahlers, E., Cook, J., Barrett, B. and Anderson, J. (1991). Preparation and clinical utility of leukocyte poor apheresis platelets. Transfusion Science, 12, 163–170.
  • Schleuning, M., Böck, M. and Wolfgang, M. (1994). Complement activation during storage of single-donor platelet concentrates. Vox Sang, 67, 144–148.
  • Frewin, D. B., Jonsson, J. R., Frewin, C. R., Russell, W. J., Russell, M. W., Davis, K. G. and Beal, R. W. (1989). Influence of blood storage time and plasma histamine levels on the pattern of transfusion reactions. Vox Sang, 56, 243–246.
  • Silliman, C. C., Paterson, A. J., Dickey, W. O., Stroncek, D. F., Popovsky, M. A., Caldwell, S. A. and Ambruso, D. R. (1997). The association of biologically active lipids with the development of transfusion-related acute lung injury: A retrospective study. Transfusion, 37, 719–726.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.